CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma

BACKGROUND: Comparative genetic and biological studies on malignant tumor counterparts in human beings and laboratory mice may be powerful gene discovery tools for blood cancers, including neoplasms of mature B-lymphocytes and plasma cells such as Burkitt lymphoma (BL) and multiple myeloma (MM). MET...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Exp Hematol Oncol
Huvudupphovsmän: Han, Seong-Su, Tompkins, Van S, Son, Dong-Ju, Han, Sangwoo, Yun, Hwakyung, Kamberos, Natalie L, Dehoedt, Casey L, Gu, Chunyan, Holman, Carol, Tricot, Guido, Zhan, Fenghuang, Janz, Siegfried
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2015
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4383050/
https://ncbi.nlm.nih.gov/pubmed/25838973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-015-0005-2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk